Literature DB >> 8725178

Development and characterization of a conditionally transformed adult human osteoblastic cell line.

P V Bodine1, M Trailsmith, B S Komm.   

Abstract

Many osteoblastic cell lines are currently in use, but these have limitations either in terms of their relevance to adult human biology and disease or in terms of their suitability for biochemical and molecular analyses. Consequently, we undertook the development of conditionally transformed adult human osteoblastic cell lines. Osteoblasts were obtained from a normal explant cancellous bone chip culture. These cells were infected with adenovirus-ori-SV40 tsA 209, which encodes a temperature-sensitive large T-antigen mutant. Cells immortalized with this virus express a transformed phenotype at the permissive temperature of 34 degrees C but revert to a normal phenotype at the nonpermissive temperature of 40 degrees C. Using this approach, we have isolated several cell clones and describe the characterization of one that was designated HOB-02-C1. Immunocytochemistry revealed that > 95% of the cells express the large T-antigen at both temperatures. These cells exponentially proliferate at 34 degrees C with a doubling time of approximately 2 days but irreversibly stop dividing at 40 degrees C. However, cell volume increases > 2-fold when the cells are maintained for 6 days at the higher temperature. This clone expresses alpha 1 type (I) procollagen mRNA and secretes type I procollagen C-peptide at both temperatures, although the levels were slightly elevated at 40 degrees C. The cell line expresses alkaline phosphatase activity at 34 degrees C, and the basal level of this enzyme increases 2- to 6-fold at 40 degrees C. Alkaline phosphatase activity is induced 4- to 8-fold by 1 alpha,25-dihydroxyvitamin D3 (vitamin D3) at both temperatures, but transforming growth factor-beta 1 (TGF-beta 1) suppresses enzyme expression > 90% at 40 degrees C. Vitamin D3 also induces a 10-fold increase in osteocalcin secretion when the clone is maintained at 34 degrees C, and this induction is enhanced > 8-fold at 40 degrees C. Parathyroid hormone and forskolin stimulate a 4- to 6-fold increase in the production of intracellular cyclic AMP (cAMP) by the cells at 34 degrees C, and this stimulation is enhanced 2- to 4-fold at 40 degrees C. In contrast, prostaglandin E2 stimulates a 7- to 8-fold increase in cAMP only when the cells are maintained at 34 degrees C. This cell line secretes TGF-beta 1 and interleukin-6 (IL-6) at 34 degrees C, but only the basal secretion of IL-6 increases 70% at 40 degrees C. Finally, alizarin red-S histochemical staining demonstrates that these cells produce mineralized nodules at both temperatures. In summary, the results of this study indicate that the HOB-02-C1 cells have a mature osteoblastic phenotype. Consequently, this new cell line and others obtained in a similar fashion should be valuable in vitro tools for cellular, biochemical, and molecular studies of adult human osteoblast biology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8725178     DOI: 10.1002/jbmr.5650110612

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  13 in total

1.  Development and characterization of a mouse floxed Bmp2 osteoblast cell line that retains osteoblast genotype and phenotype.

Authors:  Li-an Wu; Junsheng Feng; Lynn Wang; Yan-dong Mu; Andrew Baker; Kevin J Donly; Stephen E Harris; Mary MacDougall; Shuo Chen
Journal:  Cell Tissue Res       Date:  2011-01-27       Impact factor: 5.249

2.  Role of RANK ligand in mediating increased bone resorption in early postmenopausal women.

Authors:  Guitty Eghbali-Fatourechi; Sundeep Khosla; Arunik Sanyal; William J Boyle; David L Lacey; B Lawrence Riggs
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs.

Authors:  Caridad Martinez; Ted J Hofmann; Roberta Marino; Massimo Dominici; Edwin M Horwitz
Journal:  Blood       Date:  2007-01-30       Impact factor: 22.113

4.  Transcriptional link between blood and bone: the stem cell leukemia gene and its +19 stem cell enhancer are active in bone cells.

Authors:  John E Pimanda; Lev Silberstein; Massimo Dominici; Benjamin Dekel; Mark Bowen; Scott Oldham; Asha Kallianpur; Stephen J Brandt; David Tannahill; Berthold Göttgens; Anthony R Green
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

5.  Cell differentiation and p38(MAPK) cascade are inhibited in human osteoblasts cultured in a three-dimensional clinostat.

Authors:  Louis Yuge; Izumi Hide; Takanori Kumagai; Yasuhiro Kumei; Sin'ichi Takeda; Masamoto Kanno; Masanori Sugiyama; Katsuko Kataoka
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jan-Feb       Impact factor: 2.416

6.  Generation and characterization of two immortalized human osteoblastic cell lines useful for epigenetic studies.

Authors:  Flor M Pérez-Campo; Tobias May; Jeannette Zauers; Carolina Sañudo; Jesús Delgado-Calle; Jana Arozamena; María T Berciano; Miguel Lafarga; José A Riancho
Journal:  J Bone Miner Metab       Date:  2016-04-02       Impact factor: 2.626

7.  Relative survivability of human osteoblasts is enhanced by 39 °C and ascorbic acid after exposure to photopolymerization ingredients.

Authors:  Rupak Dua; Sharan Ramaswamy
Journal:  Cytotechnology       Date:  2012-11-02       Impact factor: 2.058

8.  Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation.

Authors:  Edward J Caterson; Leon J Nesti; Keith G Danielson; Rocky S Tuan
Journal:  Mol Biotechnol       Date:  2002-03       Impact factor: 2.860

9.  Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma.

Authors:  David M Thomas; Sandra A Johnson; Natalie A Sims; Melanie K Trivett; John L Slavin; Brian P Rubin; Paul Waring; Grant A McArthur; Carl R Walkley; Andrew J Holloway; Dileepa Diyagama; Jonathon E Grim; Bruce E Clurman; David D L Bowtell; Jong-Seo Lee; Gabriel M Gutierrez; Denise M Piscopo; Shannon A Carty; Philip W Hinds
Journal:  J Cell Biol       Date:  2004-12-06       Impact factor: 10.539

10.  Wee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomas.

Authors:  Jenny M Kreahling; Parastou Foroutan; Damon Reed; Gary Martinez; Tiffany Razabdouski; Marilyn M Bui; Meera Raghavan; Douglas Letson; Robert J Gillies; Soner Altiok
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.